bioGenous
Latest round
- Series A
Last raised
- Dec 2024
Total raised
- $15M
Investors
- 4
About bioGenous
Established in 2021 and based in Suzhou, China, bioGenous is a biotechnology company that focuses on cell technology development and application, human stem cell technology development and application, human gene diagnosis and therapy technology development. The company has a 3,000-square-meter R&D and production base, and three R&D and operation centers in Suzhou, Shanghai and Dezhou. The company provides production services such as organoid automation equipment, multi-tissue whole process kits, organoid culture and sample library construction technology solutions, organoid drug development and precision medicine subsystems. Their self-developed products such as multi-disease models and new drug development platforms such as human-derived organoid new crown infection model, maternal cell tumorigenesis model, fully automated organoid library building and high-throughput drug screening platform, innovative organoid models based on tissue and tumor microenvironment analysis. The company generates revenue by researching biomedical sciences and developing drugs. The company will used the funds for developing markets in China and overseas, production base construction and innovative technology development.
Who invested in bioGenous
4 investors across 3 rounds
See all investors in bioGenous
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about bioGenous
Who invested in bioGenous?
bioGenous has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has bioGenous raised?
bioGenous has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did bioGenous last raise money?
bioGenous's most recent round on record is a Series A, in Dec 2024.
What does bioGenous do?
Established in 2021 and based in Suzhou, China, bioGenous is a biotechnology company that focuses on cell technology development and application, human stem cell technology development and application, human gene diagnosis and therapy technology development.
Where is bioGenous headquartered?
bioGenous is headquartered in Suzhou, China.
Which VCs invest in companies like bioGenous?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at bioGenous's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like bioGenous? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.